1Wykrzykowska J J, Onuma Y, Serruys PW. Advances in stent drug delivery: the future is in bioabsorbable stents[ J]. Expert Opin Drug Deliv, 2009,6(2) :113-126.
2Guo Q, Guo S, Wang Z. A type of esophageal stent coating composed of one 5-fluorouracil-containing EVA layer and one drug-free protective lay- er: nvitro release, permeation and mechanical properties[ J]. J Control Release, 2007,118(3) :318-324.
3Lei L, Liu X, Guo S, et al. 5-Fluorouracil-loaded multilayered films for drug controlled releasing stent application : Drug release, microstructure, and ex vivo permeation behaviors[J]. J Control Release, 2010,146( 1 ) : 45-53.
4Machan L. Clinical experience and applications of drug-eluting stems in the noncoronary vasculature, bile duct and esophagus[ J]. Adv Drug De- liv Rev, 2006,58(3) :447-462.
5Jeon SR, Eun SH, Shim CS, et al. Effect of drug-eluting metal stents in benign esophageal stricture: an in vivo animal study[J]. Endoscopy, 2009, 41(5) : 449-456.
6Lee DK, Kim HS, Kim KS, et al. The effect on porcine bile duct of ametallic stent covered with a paclitaxel-incorporated membrane [ J ]. Gastroi- ntest Endosc, 2005,61 (2) :296-301.
7Suk KT, Kim JW, Kim HS, et al. Human application of a metallic stent covered with a paclitaxel-incorporated membrane for malignant biliary obstruction : multicenter pilot study [ J ]. Gastrointest Endosc, 2007,66 (4) :798-803.
8Song TJ, Lee SS, Yun SC, et al. Paclitaxel-eluting covered metal stents versus covered metal stents for distal malignant biliary obstruction : a pro- spective comparative pilot study[ J]. Gastrointest Endosc, 2011,73 (4) :727-733.
10Freudenberg S, Rewerk S, Kaess M, et al. Biodegradation of absorbable sutures in body fluids and pH buffers [ J ]. Eur Surg Res, 2004, 36 (6) : 376-385.
2Liu Y,Liu JL, Cai ZZ, et al. A novel approach for treatment of unresectable pancreatic cancer: design of radioactive stents and trial studies on normal pigs. Clin Cancer Res, 2(/07, 13: 3326- 3332.
3Liu Y,Liu JL,Li ZS, et al. Intraluminal implantation of radioac- tive stents for treatment of primary carcinomas of the peripancre- atic-head region: a pilot study. Gastrointest Endosc, 2009, 69: I O67-1073.
